A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis

Kidney International

Volumn 56, Issue 6, 1999, Pages 2220-2226

  Cattran, Daniel C ^{a,b,c,d,e,f,g,h}   Appel, Gerald B ^{a,b,c,d,e,f,g}   Hebert, Lee A ^{a,b,c,d,e,f,g}   Hunsicker, Lawrence G ^{a,b,c,d,e,f,g}   Pohl, Marc A ^{a,b,c,d,e,f,g}   Hoy, Wendy E ^{a,b,c,d,e,f,g}   Maxwell, Doug R ^{a,b,c,d,e,f,g}   Kunis, Cheryl L ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF TORONTO   (Canada)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f LOVELACE CLINIC FOUNDATION   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CCRW3 884 ^*  (Canada)

Author keywords

Cyclosporine; FSGS; Glomerulonephritis; Immunosuppression; Nephrotoxicity

Indexed keywords

CYCLOSPORIN; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DEMOGRAPHY; DOSE RESPONSE; FEMALE; GLOMERULOSCLEROSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0033431022     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00778.x     Document Type: Article

References (45)

1. 1. US Renal Data System: USRDS: 1995 Annual Data Report. Bethesda, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1995
2. 2. US Renal Data System: USRDS: 1997 Annual Data Report. Bethesda, The National Institute of Health, National Institutes of Diabetes and Digestive and Kidney Disease, 1997
3. 3. Rich AR: A hitherto undescribed vulnerability of the juxta-medullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100:173-187, 1957
4. 4. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG: The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:211-218, 1978
5. 5. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P: Evidence suggesting under treatment in adults with idiopathic focal segmental glomerulosclerosis. Am J Med 82:938-944, 1987
6. 6. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerulosclerosis in adults: Presentation, course and response to treatment. Am J Kidney Dis 25:534-542, 1995
7. 7. Banfi G, Moriggi M, Sabadini E, Fellin G, D'Amico G, Ponticelli C: The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults: A collaborative retrospective study. Clin Nephrol 36:53-59, 1991
8. 8. Miyata J, Takebayashi S, Taguchi T, Naito S, Harada T: Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis. Nephron 44:115-120, 1986
9. 9. Tarshish P, Tobin JN, Bernstein J, Edelmann CH Jr: Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis: A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590-593, 1996
10. 10. Newman J, Tisher C, McCoy R, Gunnells JC, Krueger RP, Clapp JR, Robinson RR: Focal glomerulosclerosis - Contrasting clinical patterns in children and adults. Medicine (Baltimore) 55:67-87, 1976
11. 11. Mongeau JG, Robitaille PO, Clemont MJ, Merouani A, Russo MP: Focal segmental glomerulosclerosis (FSG) 20 years later: From toddler to grown up. Clin Nephrol 43:137-138, 1995
12. 12. Inguilli E, Tejani A: Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol 5:393-397, 1991
13. 13. Korbet SM, Genchi RM, Borok RZ, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 27:647-651, 1996
14. 14. Howie AJ, Brewer DP: A previously undescribed type of segmental glomerular abnormality. J Pathol 142:205-220, 1984
15. 15. Schwartz MM, Korbet SM, Rydell J, Borok R, Genchi R: Primary focal segmental glomerular sclerosis in adults: Prognostic value of histologic variants. Am J Kidney Dis 25:845-852, 1995
16. 16. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424, 1994
17. 17. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Della Casa-Alberighi O: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43:1377-1384, 1993
18. 18. Lieberman KV, Tejani A, New York-New Jersey Pediatric Nephrology Study Group: A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 7:56-63, 1996
19. 19. Ponticelli C, Edefonti A, Ghio L, Rizzani G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, Bettinelli A, Maschio G, Cinotti GA, Fuiano G, Schena FP, Castellani A, Della Casa-Alberighi O: Cydosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 8:1326-1332, 1993
20. 20. Canadian Multicentre Transplant Study Group: A randomized clinical trial of cyclosporine in cadaveric renal transplantation at three years. N Engl J Med 314:1219-1225, 1986
21. 21. Cattran DC, Dossetor J, Halloran PF, Cardella C, Stiller C, Keown P, Clark WF: Cyclosporin in glomerulonephritis: A pilot study, in Cyclosporin in Autoimmune Diseases, edited by Schindler R, Berlin, Springer-Verlag, 1985, pp 311-315
22. 22. Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ: The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: A multicenter study in Korea. Clin Nephrol 43:375-381, 1995
23. 23. Walker RG, Kincaid-Smith P: The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with cyclosporin. Nephron 54:117-121, 1990
24. 24. Brodehl J, Brandis M, Helmchen U, Hoyer PI, Burghard R, Ehrich JH, Zimmerhackl RB, Klein W, Wonigeit K: Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Klin Wochenschr 66:1126-1137, 1988
25. 25. Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, Bunchman TE: Long-term cyclosporine therapy for pediatric nephrotic syndrome: A clinical and histologic analysis. J Am Soc Nephrol 7:543-549, 1996
26. 26. Capodicasa G, De Santo NG, Nuzzi F, Giordano C: Cyclosporin A in nephrotic syndrome of childhood: A 14 month experience. Int J Pediatr Nephrol 7:69-72, 1986
27. 27. Niaudet P, Broyer M, Habib R: Treatment of idiopathic nephrotic syndrome with cyclosporine A in children. Clin Nephrol 35(Suppl 1):31-36, 1991
28. 28. Hino SH, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K: Follow up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine. Am J Kidney Dis 31:932-939, 1998
29. 29. Meyrier A, Condamin M-C, Broneer D, Collaborative Group of the French Society of Nephrology: Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis. Clin Nephrol 35(Suppl 1):37-42, 1991
30. 30. Meyrier A, Noel L-H, Aurichi; P, Callard P, Collaborative Group of the Societe De Nephrologie: Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 45:1446-1456, 1994
31. 31. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A: Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5:1820-1825, 1995
32. 32. Myers BD, Sibley R, Newton L, Tomlanovich SJ, Boshkos C, Stinson E, Luetscher JA, Whitney DJ, Krasny D, Coplon NS, Perlroth MG: The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 33:590-600, 1988
33. 33. Palestine AG, Austin HA, Balow JE, Antonovych TT, Sabnis SG, Preuss HG, Nussenblatt RB: Renal hislopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 314:1293-1298, 1986
34. 34. Statistical Analysis System (version 6.12). Cary, SAS Institute, 1989-1996
35. 35. Cook RJ, Sackett DL: The number needed to treat: A clinically useful measure of treatment effect. Br Med J 310:452-454, 1995
36. 36. Cattran DC, Panduranga R: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32:72-79, 1998
37. 37. Collaborative Study Group of Sandimmun in Nephrotic Syndrome: Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Clin Nephrol 35(Suppl 1):48-60, 1991
38. 38. McNally PG, Feehally J: Pathology of cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant 7:791-804, 1992
39. 39. Pei Y, Chan C, Maurer J, Cardella C, Cattran D: Sustained renal vasoconstriction associated with daily CyA dose in heart and lung transplant recipients: Potential pathophysiologic role of endothelin. J Lab Clin Med 125:113-119, 1995
40. 40. Cattran D, Greenwood C, Ritchie S, Bernstein K, Churchill D, Clark W, Morrin P, Lavoie S, Canadian Glomerulonephritis Study Group: A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 47:1130-1135, 1995
41. 41. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
42. 42. Klahr S, Levey A, Beck G, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
43. 43. Gansevoort RT, de Zeeuw D, de Jong PE: Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant 10:497-504, 1995
44. 44. D'Amico G, Gentile MG, Fellin G, Manna G, Cofano F: Effect of dietary protein restriction on the progression of renal failure: A prospective randomized trial. Nephrol Dial Transplant 9:1590-1594, 1994
45. 45. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria and the progression of renal disease. Ann Intern Med 123:754-762, 1995